Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future
Open Access
- 6 March 2021
- Vol. 10 (3), 580
- https://doi.org/10.3390/cells10030580
Abstract
For nearly a decade, researchers in the field of pediatric oncology have been using zebrafish as a model for understanding the contributions of genetic alternations to the pathogenesis of neuroblastoma (NB), and exploring the molecular and cellular mechanisms that underlie neuroblastoma initiation and metastasis. In this review, we will enumerate and illustrate the key advantages of using the zebrafish model in NB research, which allows researchers to: monitor tumor development in real-time; robustly manipulate gene expression (either transiently or stably); rapidly evaluate the cooperative interactions of multiple genetic alterations to disease pathogenesis; and provide a highly efficient and low-cost methodology to screen for effective pharmaceutical interventions (both alone and in combination with one another). This review will then list some of the common challenges of using the zebrafish model and provide strategies for overcoming these difficulties. We have also included visual diagram and figures to illustrate the workflow of cancer model development in zebrafish and provide a summary comparison of commonly used animal models in cancer research, as well as key findings of cooperative contributions between MYCN and diverse singling pathways in NB pathogenesis.Keywords
Funding Information
- National Cancer Institute (R01 CA240323)
- U.S. Department of Defense (W81XWH-17-1-0498)
- V Foundation for Cancer Research (D2018-005)
This publication has 123 references indexed in Scilit:
- In vivo genome editing using a high-efficiency TALEN systemNature, 2012
- Activated ALK Collaborates with MYCN in Neuroblastoma PathogenesisCancer Cell, 2012
- NeuroblastomaAdvances in Pediatrics, 2011
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- Vertebrate genome evolution and the zebrafish gene mapNature Genetics, 1998
- Insertional mutagenesis and rapid cloning of essential genes in zebrafishNature, 1996